LivaNova PLC

NASDAQ (USD): LivaNova PLC (LIVN)

Last Price

46.75

Today's Change

-0.24 (0.51%)

Day's Change

46.61 - 47.15

Trading Volume

132,393

Overview

Market Cap

2 Billion

Shares Outstanding

54 Million

Avg Volume

495,336

Avg Price (50 Days)

51.49

Avg Price (200 Days)

52.81

PE Ratio

108.72

EPS

0.43

Earnings Announcement

19-Feb-2025

Previous Close

46.99

Open

47.15

Day's Range

46.61 - 47.15

Year Range

43.15 - 64.475

Trading Volume

132,393

Price Change Highlight

1 Day Change

-0.51%

5 Day Change

-2.16%

1 Month Change

-8.90%

3 Month Change

-9.19%

6 Month Change

-14.14%

Ytd Change

-7.50%

1 Year Change

-9.87%

3 Year Change

-46.44%

5 Year Change

-37.96%

10 Year Change

-33.15%

Max Change

-33.15%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Medical Devices

Description:

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products, such as cardiopulmonary and respiratory support solutions. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment